Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral Supra-Zygomatic Sphenopalatine Ganglion Block Versus Dexmedetomidine for Relief of Postoperative Pain and Surgical Field Improvement in Trans-nasal Endoscopic Pituitary Surgery

NCT06639659 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT06639659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06639659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral Supra-Zygomatic Sphenopalatine Ganglion Block Versus Dexmedetomidine for Relief of Postoperative Pain and Surgical Field Improvement in Trans-nasal Endoscopic Pituitary Surgery
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2024
Completion date
October 31, 2026
Enrollment
69 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sphenopalatine ganglion nerve block, transnasal endoscopic pitutary surgery